Clinical Trials Logo

Other clinical trials

View clinical trials related to Other.

Filter by:

NCT ID: NCT04113824 Completed - Clinical trials for Neck Pain, Posterior

The Efficacy and Safety of Trapezius MSAT on Acute Whiplash Injury

Start date: July 3, 2019
Phase: N/A
Study type: Interventional

This study is a double blind, randomized controlled trail. condition/disease: acute neck pain treatment/intervention: motion style acupuncture treatment

NCT ID: NCT04113551 Completed - Clinical trials for Attention Deficit Disorder With Hyperactivity

A Study of Label Compliance for Attention Deficit/Hyperactivity Disorder (ADHD) Medications in Japan

Start date: October 1, 2019
Phase:
Study type: Observational

The purpose of this study is to document the extent of on-label and off-label use of Methylphenidate (MPH) (Concerta), MPH (Ritalin), Atomoxetine (ATO), and Guanfacine (GFC) in Japan.

NCT ID: NCT04113265 Completed - Clinical trials for Skin Flaccidity Inner Thighs Knees Arms

Aesthetic Performance of an Injective Treatment for the Inner Thighs, Knees and Arms

Start date: May 20, 2019
Phase: N/A
Study type: Interventional

The objective of this study is to investigate the efficacy of the "SUNEKOS® Body" in woman aged 40-65 years with skin flaccidity of the inner thighs, knees and arms.

NCT ID: NCT04113187 Completed - Clinical trials for Hereditary Hemorrhagic Telangiectasia

Propranolol for Epistaxis in Hereditary Hemorrhagic Telangiectasia Patients

EPERO
Start date: June 23, 2020
Phase: Phase 3
Study type: Interventional

Hereditary Hemorrhagic Telangiectasia (HHT) is a genetic disorder of angiogenesis associated with disabling epistaxis. Management of these nose bleedings requires more effective treatment. Propranolol, a beta-blocker, is a potentially useful therapeutic considering its anti-angiogenic properties. Our objective is to explore the efficacy of propranolol, three months after its introduction, on the cumulative duration of epistaxis in HHT patients.

NCT ID: NCT04112849 Completed - Heart Failure Clinical Trials

Electronic S3 Prediction of Hospital Readmissions for HF Exacerbation

Start date: March 11, 2020
Phase:
Study type: Observational

The study objective is to measure the value of the third heart sound (S3) for the prediction of recurrent heart failure (HF). For the purpose of this study, a heart failure event will be defined as a hospitalization with a primary diagnosis of heart failure. The main hypothesis of the study is that measurement of S3, using a microelectronic machine microphone positioned in a wearable device (Nanowear Wearable Congestive Heart Failure Management System) near the time of discharge from a hospitalization for heart failure, can predict which patients will be at high risk for a heart failure event, thereby identifying a group in whom increased surveillance and monitoring may decrease hospital readmissions for worsening heart failure.

NCT ID: NCT04112771 Completed - Clinical trials for Postoperative Nausea and Vomiting

Penehyclidine and Postoperative Nausea and Vomiting After Bimaxillary Surgery

Start date: October 7, 2019
Phase:
Study type: Observational

Postoperative nausea and vomiting (PONV) are common complications after surgery. Patients undergoing orthognathic surgery are reported to have a high rate of PONV, especially those undergoing bimaxillary surgery. Activation of cholinergic system plays an important role in the development of PONV. Penehyclidine is an muscarinic antagonists which selectively block M1 and M3 receptors and is commonly used to decrease oral secretion. The purpose of this retrospective cohort study is to investigate whether use of penehyclidine is associated with a reduced risk of PONV in patients undergoing bimaxillary surgery.

NCT ID: NCT04112472 Completed - Clinical trials for Optical Biometry of the Human Eye

Clinical Trial ES 900 - 2019

Start date: July 11, 2019
Phase: N/A
Study type: Interventional

The primary objective of this clinical trial is to assess the clinical performance of the investigational device. To that end, the Limits of Agreement with respect to comparator devices are analyzed. The Limits of Agreement allow estimating the expected measurement deviation per measurand, which is compared to the "maximum acceptable measurement error", as defined by the Risk Analysis of the investigational device, to assess the risk involved in measurements of the investigational device. Furthermore, the in-vivo repeatability will be quantified for each measurand, as well as the confidence intervals for mean deviation with respect to the current gold standard device. As a secondary objective of the study, raw measurement data will be collected to allow for improvement of existing algorithms, development of additional measurands and for retrospective analysis.

NCT ID: NCT04112316 Completed - Clinical trials for Heart Failure With Reduced Ejection Fraction

Developing Oral LT3 Therapy for Heart Failure - HFrEF

DOT3HF-HFrEF
Start date: February 11, 2020
Phase: Phase 1/Phase 2
Study type: Interventional

Investigation of the safety, feasibility, and preliminary efficacy of thyroid hormone therapy with Liothyronine (LT3) in individuals with heart failure with reduced ejection fraction (HFrEF) and low triiothyronine (T3) syndrome by conducting a randomized, double-blind, placebo-controlled cross-over study with a two week washout period between treatments.

NCT ID: NCT04112004 Completed - Clinical trials for Perioperative/Postoperative Complications

Effect Of Delta Sodium on the Postoperative Outcomes in Liver Transplant Recipients

SOLT
Start date: January 1, 2011
Phase:
Study type: Observational

We analyzed the association of delta sodium levels with their effect on post liver transplant outcomes in consecutive patients undergoing liver transplantation. Records were analyzed for electrolytes and outcome measures, and data was analyzed.

NCT ID: NCT04111744 Completed - Clinical trials for Coronary Artery Disease

Preoperative Excercise Training for Patients Undergoing Coronary Artery Bypass Graft Surgery

Start date: January 1, 2015
Phase: N/A
Study type: Interventional

Patients (pts) with stable coronary artery disease (CAD) requiring coronary artery bypass graft surgery (CABG) may be physically inactive during the waiting period to avoid further risks. Aim of this study is to investigate the feasibility and safety of a preoperative aerobic exercise training in these pts during the waiting period and to analyze its effects on pre-, peri and postoperative outcomes